📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Genomill

1.1 - Company Overview

Genomill Logo

Genomill

Headquarter: Finland
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of precision diagnostics solutions, including Bridge Capture, a laboratory process for targeted DNA sequencing offering cost-efficient, sensitive, platform-agnostic molecular quantification suitable for oncological applications; Nicking Loop, a PCR-free DNA amplification method enabling high-fidelity data copying and querying compatible with any sequencing platform; and Geno1, an NGS platform enhancing cost, performance, and scalability of liquid biopsy diagnostics.

Products and services

  • Geno1®: A scalable technology platform that enhances cost, performance, and scalability of liquid biopsy diagnostics using next-generation sequencing
  • Bridge Capture™: A platform-agnostic laboratory process for targeted DNA sequencing that delivers cost-efficient, sensitive molecular quantification, suitable for oncological applications
  • Nicking Loop™: A PCR-free DNA amplification method that enables high-fidelity data copying and querying, and remains compatible with any sequencing platform

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Genomill

Predicine Logo

Predicine

HQ: United States Website
  • Description: Provider of genomic profiling tests and algorithms for cancer diagnostics and monitoring, including PredicineATLAS (600-gene NGS with TMB/MSI), PredicineCARE (152-gene cfDNA for treatment selection), PredicineRNA (88-gene cfRNA for fusions/splicing), PredicineHEME (259-gene for hematologic malignancies), PredicineBEACON (MRD tracking), and PredicineWES+ (liquid biopsy exome sequencing for clinical trials).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Predicine company profile →
BioFire Diagnostics Logo

BioFire Diagnostics

HQ: United States Website
  • Description: Provider of multiplex PCR-based clinical diagnostics, offering the BIOFIRE and BIOFIRE FILMARRAY systems for rapid, comprehensive syndromic infectious disease testing, FDA-cleared FILMARRAY Panels for viruses, bacteria, and antimicrobial resistance genes, the high-throughput FILMARRAY TORCH, and SPOTFIRE point-of-care respiratory/sore throat solutions delivering results in about an hour or about 15 minutes.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BioFire Diagnostics company profile →
Applied Microarrays Logo

Applied Microarrays

HQ: United States Website
  • Description: Provider of design, optimization and manufacturing services for DNA and protein biosensors and other microarrays on glass, plastic and semiconductors.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Applied Microarrays company profile →
NantOmics Logo

NantOmics

HQ: United States Website
  • Description: Provider of cloud-based molecular profiling tools for cancer care, including GPS Cancer, a comprehensive test integrating DNA sequencing, RNA sequencing, and proteomics to guide personalized treatment; an integrated panomic approach to detect tumor alterations; and machine vision AI software analyzing digital pathology to identify cancer subtypes and therapy resistance mechanisms.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NantOmics company profile →
Geneoscopy Logo

Geneoscopy

HQ: United States Website
  • Description: Provider of noninvasive, stool-based diagnostics for gastrointestinal diseases, including an at-home colorectal cancer and advanced adenoma screening test; inflammatory bowel disease diagnostic solutions; RNA-based diagnostic research; and a stool biobank with biomarker analysis for diagnostic, prognostic, and predictive applications.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Geneoscopy company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Genomill

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Genomill

2.2 - Growth funds investing in similar companies to Genomill

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Genomill

4.2 - Public trading comparable groups for Genomill

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Genomill

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Genomill

What does Genomill do?

Genomill is a provider of precision diagnostics solutions, including Bridge Capture, a laboratory process for targeted DNA sequencing offering cost-efficient, sensitive, platform-agnostic molecular quantification suitable for oncological applications; Nicking Loop, a PCR-free DNA amplification method enabling high-fidelity data copying and querying compatible with any sequencing platform; and Geno1, an NGS platform enhancing cost, performance, and scalability of liquid biopsy diagnostics.

Who are Genomill's competitors?

Genomill's competitors and similar companies include Predicine, BioFire Diagnostics, Applied Microarrays, NantOmics, and Geneoscopy.

Where is Genomill headquartered?

Genomill is headquartered in Finland.

How many employees does Genomill have?

Genomill has 1,000 employees 🔒.

When was Genomill founded?

Genomill was founded in 2010 🔒.

What sector and industry vertical is Genomill in?

Genomill is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Genomill

Who are the top strategic acquirers in Genomill's sector and industry

Top strategic M&A buyers and acquirers in Genomill's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Genomill?

Top strategic M&A buyers groups and sectors for Genomill include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Genomill's sector and industry vertical

Which are the top PE firms investing in Genomill's sector and industry vertical?

Top PE firms investing in Genomill's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Genomill's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Genomill's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Genomill's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Genomill include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Genomill's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Genomill?

The key public trading comparables and valuation benchmarks for Genomill include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Genomill for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Genomill with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Genomill's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Genomill with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Genomill's' sector and industry vertical?

Access recent funding rounds and capital raises in Genomill's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Genomill